|
NAEPP
Severity Level Classifications
|
Clinical features
before treatment*
|
|
|
Symptoms**
|
Nighttime symptoms
|
Lung function
|
|
Step1
Mild intermittent
|
·
Symptoms ≤ 2 times a week
·
Asymptomatic and
normal PEF between exacerbations
·
Exacerbations brief
(from a few hours to a few days)
|
≤ 2 times a month
|
·
FEV1 or PEF
≥ 80% predicted
·
PEF variability <
20%
|
|
Step 2
Mild persistent
|
·
Symptoms > 2 times
a week but < 1 time a day
·
Exacerbations may
affect activity
|
> 2 times a month
|
·
FEV1 or PEF
≥ 80% predicted
·
PEF variability 20-30%
|
|
Step 3
Moderate persistent
|
·
Daily symptoms
·
Daily use of inhaled
short-acting beta2 agonists
·
Exacerbations affect
activity
·
Exacerbations ≥ 2 times
a week; may last days
|
> 1 time a week
|
·
FEV1 or PEF
> 60% - < 80% predicted
·
PEF variability >
30%
|
|
Step 4
Severe persistent
|
·
Continual symptoms
·
Limited physical
activity
·
Frequent exacerbations
|
Frequent
|
·
FEV1 or PEF
≤ 60% predicted
·
PEF variability >
30%
|
|
*Presence of one
of the features of severity is sufficient to place a patient in that
category. An individual should
be assigned to the most severe grade in which any feature occurs. Characteristics noted in this figure are
general and may overlap because asthma is highly variable. An individual’s
classification may change over time.
**Patients at any
level of severity can have mild, moderate, or severe exacerbations. Some
patients with intermittent asthma experience severe and life-threatening
exacerbations separated by long periods of normal lung function and no
symptoms.
|